» Articles » PMID: 32903597

NAD Metabolism As an Emerging Therapeutic Target for Cardiovascular Diseases Associated With Sudden Cardiac Death

Overview
Journal Front Physiol
Date 2020 Sep 9
PMID 32903597
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

In addition to its central role in mediating oxidation reduction in fuel metabolism and bioenergetics, nicotinamide adenine dinucleotide (NAD) has emerged as a vital co-substrate for a number of proteins involved in diverse cellular processes, including sirtuins, poly(ADP-ribose) polymerases and cyclic ADP-ribose synthetases. The connection with aging and age-associated diseases has led to a new wave of research in the cardiovascular field. Here, we review the basics of NAD homeostasis, the molecular physiology and new advances in ischemic-reperfusion injury, heart failure, and arrhythmias, all of which are associated with increased risks for sudden cardiac death. Finally, we summarize the progress of NAD-boosting therapy in human cardiovascular diseases and the challenges for future studies.

Citing Articles

Cardiac NAD depletion in mice promotes hypertrophic cardiomyopathy and arrhythmias prior to impaired bioenergetics.

Doan K, Luongo T, Tsolo T, Lee W, Frederick D, Mukherjee S Nat Cardiovasc Res. 2024; 3(10):1236-1248.

PMID: 39294272 DOI: 10.1038/s44161-024-00542-9.


Microtubules Sequester Acetylated YAP in the Cytoplasm and Inhibit Heart Regeneration.

Liu S, Deshmukh V, Meng F, Wang Y, Morikawa Y, Steimle J Circulation. 2024; 151(1):59-75.

PMID: 39185559 PMC: 11671299. DOI: 10.1161/CIRCULATIONAHA.123.067646.


Cardiomyocyte-specific deletion of the mitochondrial transporter Abcb10 causes cardiac dysfunction via lysosomal-mediated ferroptosis.

Do Y, Yagi M, Hirai H, Miki K, Fukahori Y, Setoyama D Biosci Rep. 2024; 44(5).

PMID: 38655715 PMC: 11088307. DOI: 10.1042/BSR20231992.


Postmortem Alteration of Purine Metabolism in Coronary Artery Disease.

Somtua P, Jaikang C, Konguthaithip G, Intui K, Watcharakhom S, OBrien T Metabolites. 2023; 13(11).

PMID: 37999231 PMC: 10673240. DOI: 10.3390/metabo13111135.


Nicotinamide Riboside, an NAD + Precursor, Protects Against Cardiac Mitochondrial Dysfunction in Fetal Guinea Pigs Exposed to Gestational Hypoxia.

Thompson L, Song H, Hartnett J Reprod Sci. 2023; 31(4):975-986.

PMID: 37957471 PMC: 10959782. DOI: 10.1007/s43032-023-01387-6.


References
1.
Zhou H, Swanson R, Simonis U, Ma X, Cecchini G, Gray M . Poly(ADP-ribose) polymerase-1 hyperactivation and impairment of mitochondrial respiratory chain complex I function in reperfused mouse hearts. Am J Physiol Heart Circ Physiol. 2006; 291(2):H714-23. DOI: 10.1152/ajpheart.00823.2005. View

2.
DAmours D, Desnoyers S, DSilva I, Poirier G . Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions. Biochem J. 1999; 342 ( Pt 2):249-68. PMC: 1220459. View

3.
Zipes D, Wellens H . Sudden cardiac death. Circulation. 1998; 98(21):2334-51. DOI: 10.1161/01.cir.98.21.2334. View

4.
Carbone F, Liberale L, Bonaventura A, Vecchie A, Casula M, Cea M . Regulation and Function of Extracellular Nicotinamide Phosphoribosyltransferase/Visfatin. Compr Physiol. 2017; 7(2):603-621. DOI: 10.1002/cphy.c160029. View

5.
Schilling E, Hauschildt S . Extracellular ATP induces P2X7-dependent nicotinamide phosphoribosyltransferase release in LPS-activated human monocytes. Innate Immun. 2012; 18(5):738-44. DOI: 10.1177/1753425912439614. View